152438-62-5

Basic information

• Product Name: Carbamic acid, [(1S)-3-chloro-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]propyl]-, 1,1-dimethylethyl ester
• CAS NO: 152438-62-5
• Molecular Formula: C22H26ClNO4
• Molecular Weight: 403.906
• Mol File: 152438-62-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S)-3-chloro-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]propyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S)-3-chloro-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]propyl]-, 1,1-dimethylethyl ester(152438-62-5)
• EPA Substance Registry System: Carbamic acid, [(1S)-3-chloro-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]propyl]-, 1,1-dimethylethyl ester(152438-62-5)

Safety Data

• Hazardous Substances Data: 152438-62-5(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 114645-18-0 [1-(4-benzyloxy-benzyl)-3-diazo-2-oxo-propyl]-carbamic acid tert-butyl ester 
• 593-71-5 Chloroiodomethane 
• 127132-32-5 ethyl N-{[(1,1-dimethylethyl)oxy]carbonyl}-O-(phenylmethyl)-L-tyrosinate 
• 27513-44-6 N-tert-butoxycarbonyl-O-benzyl-(S)-tyrosine methyl ester 
• 79-11-8 chloroacetic acid 
• 2130-96-3 O-benzyl-N-tert-butoxycarbonyl-L-tyrosine 
• 1026977-99-0 C₂₆H₃₃NO₇ 
• 34619-03-9 tert-butyldicarbonate 

Downstream Products

• 152438-67-0 Boc-Tyr(Bzl)-4-acetylphenoxymethyl ketone 
• 1059189-63-7 [(S)-1-(4-Benzyloxy-benzyl)-3-chloro-2-hydroxy-propyl]-carbamic acid tert-butyl ester 
• 1256492-59-7 tert-butyl ((2S,3S)-1-(4-(benzyloxy)phenyl)-4-chloro-3-hydroxybutan-2-yl)carbamate-d1 
• 1443118-23-7 tert-butyl ((S)-2-(4-(benzyloxy)phenyl)-1-((S)-oxiran-2-yl)ethyl)carbamate-d1 
• 1256492-92-8 C₃₃H₃₀⁽²⁾H₁₂N₂O₈S 
• 1443118-24-8 C₂₈H₂₂⁽²⁾H₁₂N₂O₆S 
• 1443118-36-2 C₃₅H₂₅⁽²⁾H₁₇N₂O₁₀S 
• 1443118-37-3 C₃₅H₂₈⁽²⁾H₁₄N₂O₁₀S 
• 1443118-39-5 C₃₈H₃₂⁽²⁾H₁₄N₂O₁₀S 
• 1443118-41-9 C₃₁H₂₆⁽²⁾H₁₄N₂O₁₀S 
• 1443118-38-4 C₃₈H₂₉⁽²⁾H₁₇N₂O₁₀S 
• 1443118-40-8 C₃₁H₂₃⁽²⁾H₁₇N₂O₁₀S 
• 152438-40-9 Boc-Tra-Tyr(Bzl)-4-acetylphenoxymethyl ketone 
• 152438-36-3 Boc-Tra-Tyr(Bzl)-CH₂Cl 

Relevant articles and documents

Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs

Several highly deuterated analogs of the HIV-1 protease inhibitor brecanavir have been prepared to study the effect of deuterium upon metabolic stability. The sites for deuterium incorporation were initially chosen to maximize the potential for a kinetic isotope effect; locations where C-H bond breaking is the rate limiting step. The analogs have been profiled in both in vitro and in vivo pharmacokinetic studies and the result will be described herein.

PROCESS FOR PRODUCING AMINOEPOXIDE

The present invention relates to a method of producing N-carbamate protected-3-amino-1,2-epoxy-4-(hydroxy substituted phenyl)butane at a high optical purity in a high yield, by hydrogenating N-carbamate protected-3-amino-1-chloro-2-hydroxy-4-(benzyloxy su

A practical method for the preparation of α'-chloroketones of N-carbanaate protected-α-aminoacids

A practical method for the preparation of α-N-BOC-epoxides from protected amino acid esters based on the Kowalski homologation reaction is described. This procedure can be readily performed on a large scale without the use of hazardous reagents and has allowed preparation of epoxides 3 in multi-kilogram quantities.